Exact Mass: 320.0509

Exact Mass Matches: 320.0509

Found 108 metabolites which its exact mass value is equals to given mass value 320.0509, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

trans-3,3',4',5,5',7-Hexahydroxyflavanone

4H-1-Benzopyran-4-one, 2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, (2R-trans)-

C15H12O8 (320.0532)


(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as a metabolite, an antioxidant and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin. Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus). Dihydromyricetin is a naturally occurring flavonoid found in the many plant species and is thought to be the active ingredient of several traditional Japanese, Chinese, and Korean medicines that are used to treat fever, parasite infections, liver diseases, and hangovers. Dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice. Dihydromyricetin is a natural product found in Vitis rotundifolia, Catha edulis, and other organisms with data available. (±)-trans-3,3,4,5,5,7-Hexahydroxyflavanone is found in tea. (±)-trans-3,3,4,5,5,7-Hexahydroxyflavanone is a constituent of Camellia sinensis (Chinese green tea). Constituent of Camellia sinensis (Chinese green tea). (±)-Dihydromyricetin is found in tea. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.

   

2,3-Dihydrogossypetin

(2R)-2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxy-2,3-dihydrochromen-4-one

C15H12O8 (320.0532)


A member of the class of dihydroflavonols that is the 2,3-dihydro derivative of gossypetin.

   

2,2,3-trihydroxy-3-methoxy-5,5-dicarboxybiphenyl

2,2,3-trihydroxy-3-methoxy-5,5-dicarboxybiphenyl

C15H12O8 (320.0532)


   

N-Sulfonyloxy-PhIP

N-Sulfonyloxy-PhIP

C13H12N4O4S (320.0579)


   

2,3-dihydroquercetagetin

2,3-dihydroquercetagetin

C15H12O8 (320.0532)


   

(2S)-4,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-one

4,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-one

C15H12O8 (320.0532)


   

2-[1-(2-Fluorophenyl)ethylamino]-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4-one

2-{[1-(2-fluorophenyl)ethyl]imino}-5-methyl-5-(trifluoromethyl)-1,3-thiazolidin-4-one

C13H12F4N2OS (320.0606)


   

Ethyl brevifolincarboxylate

Ethyl 7,8,9-trihydroxy-3,5-dioxo-1H,2H,3H,5H-cyclopenta[c]isochromene-1-carboxylic acid

C15H12O8 (320.0532)


Ethyl brevifolincarboxylate, also known as ebfc, belongs to isocoumarins and derivatives class of compounds. Those are polycyclic compounds containing an isochromane which bears a ketone at the carbon C1. Ethyl brevifolincarboxylate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Ethyl brevifolincarboxylate can be found in pomegranate, which makes ethyl brevifolincarboxylate a potential biomarker for the consumption of this food product.

   
   

Amaronol A

(+) -2,4,6-Trihydroxy-2- [ (3,4,5-trihydroxyphenyl) methyl ] -3 (2H) -benzofuranone

C15H12O8 (320.0532)


   

Fusarubinoic acid

Fusarubinoic acid

C15H12O8 (320.0532)


   

8-Chloro-5,7,4-trihydroxy-3-C-methylflavanone

8-Chloro-5,7,4-trihydroxy-3-C-methylflavanone

C16H13ClO5 (320.0451)


   

1,3,6,8-tetrahydroxy-2,7-dimethoxyxanthone

1,3,6,8-tetrahydroxy-2,7-dimethoxyxanthone

C15H12O8 (320.0532)


   

alternarian acid

alternarian acid

C15H12O8 (320.0532)


   

ampelopsin

4H-1-Benzopyran-4-one, 2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, (2R-trans)-

C15H12O8 (320.0532)


Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.

   

Hovenitin III

(2R,3S) -3,5,7,3,4,5-Hexahydroxyflavanone

C15H12O8 (320.0532)


   

p-Digalloyl acid

3,5-Dihydroxy-4-[(3,4,5-trihydroxybenzoyl)oxy]benzoic acid

C15H12O8 (320.0532)


   

2,5,7-Trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-on|2,5,7-trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-one

2,5,7-Trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-on|2,5,7-trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-one

C15H12O8 (320.0532)


   

CHEMBL2261304

CHEMBL2261304

C15H12O8 (320.0532)


   

(1S)-1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-6,9-dihydro-1H-naphtho[2,3-c]pyran-6,9-dione|coronatoquinone

(1S)-1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-6,9-dihydro-1H-naphtho[2,3-c]pyran-6,9-dione|coronatoquinone

C15H12O8 (320.0532)


   

9H-Xanthen-9-one, 5-chloro-8-hydroxy-1,4-dimethoxy-3-methyl-

9H-Xanthen-9-one, 5-chloro-8-hydroxy-1,4-dimethoxy-3-methyl-

C16H13ClO5 (320.0451)


   

2-chloro-1-hydroxy-3,6-dimethoxy-8-methyl-xanthen-9-one|2-Chloro-3, 6-di-O-methylnorlichexanthone

2-chloro-1-hydroxy-3,6-dimethoxy-8-methyl-xanthen-9-one|2-Chloro-3, 6-di-O-methylnorlichexanthone

C16H13ClO5 (320.0451)


   

Ethyl brevifolincarboxylate

Ethyl brevifolincarboxylate

C15H12O8 (320.0532)


   

16-bromo-(7E,11E,15E)-hexadeca-7,11,15-trien-5,13-diynoic acid

16-bromo-(7E,11E,15E)-hexadeca-7,11,15-trien-5,13-diynoic acid

C16H17BrO2 (320.0412)


   

4-dechloro-8-O-methylthiomelin|5, 8-Di-Me ether-2-Chloro-1, 5, 8-trihydroxy-6-methylxanthone

4-dechloro-8-O-methylthiomelin|5, 8-Di-Me ether-2-Chloro-1, 5, 8-trihydroxy-6-methylxanthone

C16H13ClO5 (320.0451)


   

1,3,6,8-Tetrahydroxy-2,5-dimethoxyxanthone

1,3,6,8-Tetrahydroxy-2,5-dimethoxyxanthone

C15H12O8 (320.0532)


   

CHEMBL1673300

CHEMBL1673300

C15H12O8 (320.0532)


   

(Z)-4-hydroxy-3-(7-hydroxy-4-chromoyl)-hex-2-enedioic acid

(Z)-4-hydroxy-3-(7-hydroxy-4-chromoyl)-hex-2-enedioic acid

C15H12O8 (320.0532)


   

4-Chlorolichexanthone

4-Chlorolichexanthone

C16H13ClO5 (320.0451)


   
   

Graphislactone G

Graphislactone G

C16H13ClO5 (320.0451)


   

m-Digalloyl acid

m-Digalloyl acid

C15H12O8 (320.0532)


   

Dihydromyricetin

trans-3,3,4,5,5,7-Hexahydroxyflavanone

C15H12O8 (320.0532)


A hexahydroxyflavanone that is the 2,3-dihydro derivative of myricetin. Dihydromyricetin, also known as ampelopsin or (2r,3r)-3,5,7,3,4,5-hexahydroxyflavanone, is a member of the class of compounds known as epigallocatechins. Epigallocatechins are compounds containing epigallocatechin or a derivative. Epigallocatechin is a flavan-3-ol containing a benzopyran-3,5,7-triol linked to a 3,4,5-hydroxyphenyl moiety. Dihydromyricetin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Dihydromyricetin can be found in a number of food items such as highbush blueberry, summer grape, sacred lotus, and sweet rowanberry, which makes dihydromyricetin a potential biomarker for the consumption of these food products. Hovenia dulcis has been used in traditional Japanese, Chinese, and Korean medicines to treat fever, parasitic infection, as a laxative, and a treatment of liver diseases, and as a hangover treatment. Methods have been developed to extract ampelopsin from it at large scales, and laboratory research has been conducted with the compound to see if it might be useful as a drug in any of the conditions for which the parent plant has been traditionally used . Isolated from flowers of Eugenia jambolana (jambolan). trans-3,3,4,5,5,7-Hexahydroxyflavanone is found in fruits. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.

   

CHEMBL521876

CHEMBL521876

C15H12O8 (320.0532)


   

m-Digallic acid

m-Digallic acid

C15H12O8 (320.0532)


   

Morin

2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one xhydrate

C15H12O8 (320.0532)


   

fuzhuanin A

fuzhuanin A

C15H12O8 (320.0532)


   

Hydroxyhaemoventosine

Hydroxyhaemoventosine

C15H12O8 (320.0532)


   

Flavanone base + 6O

Flavanone base + 6O

C15H12O8 (320.0532)


Annotation level-3

   

16-bromo-7E,11E,15E-hexadecatrien-5,13-diynoic acid

16-bromo-7E,11E,15E-hexadecatrien-5,13-diynoic acid

C16H17BrO2 (320.0412)


   

16-bromo-7E,11E,15Z-hexadecatrien-5,13-diynoic acid

16-bromo-7E,11E,15Z-hexadecatrien-5,13-diynoic acid

C16H17BrO2 (320.0412)


   

N-[6-[(2-chloro-4-hydroxyphenyl)imino]-4-methoxy-3-oxo-1,4-cyclohexadien-1-yl]acetamide

N-[6-[(2-chloro-4-hydroxyphenyl)imino]-4-methoxy-3-oxo-1,4-cyclohexadien-1-yl]acetamide

C15H13ClN2O4 (320.0564)


   

((7-Oxo-7H-benz(de)anthracen-3-yl)thio)acetic acid

((7-Oxo-7H-benz(de)anthracen-3-yl)thio)acetic acid

C19H12O3S (320.0507)


   

8,8-diquinolyl disulfide

8,8-diquinolyl disulfide

C18H12N2S2 (320.0442)


   

(4-((TERT-BUTYLDIMETHYLSILYL)OXY)-3,5-DICHLOROPHENYL)BORONIC ACID

(4-((TERT-BUTYLDIMETHYLSILYL)OXY)-3,5-DICHLOROPHENYL)BORONIC ACID

C12H19BCl2O3Si (320.0574)


   

4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenamine

4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenamine

C16H11F3N2S (320.0595)


   

Ethyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate

Ethyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate

C15H13ClN2O4 (320.0564)


   

Ethyl [(4-chloro-3-cyano-6-methoxy-7-quinolinyl)oxy]acetate

Ethyl [(4-chloro-3-cyano-6-methoxy-7-quinolinyl)oxy]acetate

C15H13ClN2O4 (320.0564)


   

1-(BENZYLOXY)-4-(3-BROMOPROPOXY)BENZENE

1-(BENZYLOXY)-4-(3-BROMOPROPOXY)BENZENE

C16H17BrO2 (320.0412)


   

Quercetin (hydrate)

Quercetin (hydrate)

C15H12O8 (320.0532)


   

Dipentamethylenethiuram disulfide

Methanethione,1,1-dithiobis[1-(1-piperidinyl)-

C12H20N2S4 (320.0509)


   

1-bromo-2-fluoro-4-(4-pentylphenyl)benzene

1-bromo-2-fluoro-4-(4-pentylphenyl)benzene

C17H18BrF (320.0576)


   

2-(2-BENZYLIDENEHYDRAZINYL)-5-SULFOBENZOIC ACID

2-(2-BENZYLIDENEHYDRAZINYL)-5-SULFOBENZOIC ACID

C14H12N2O5S (320.0467)


   

N-(2-Formyl-4-nitro-phenyl)-4-methyl-benzenesulfonamide

N-(2-Formyl-4-nitro-phenyl)-4-methyl-benzenesulfonamide

C14H12N2O5S (320.0467)


   

Methyl (E)-2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate

Methyl (E)-2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate

C15H13ClN2O4 (320.0564)


   

2,2,3,3,4,4-Hexafluoro-1,5-pentyl diacrylate

2,2,3,3,4,4-Hexafluoro-1,5-pentyl diacrylate

C11H10F6O4 (320.0483)


   

chloropalladium(1+),(1Z,5Z)-cycloocta-1,5-diene,2-methanidyl-2-methylpropane

chloropalladium(1+),(1Z,5Z)-cycloocta-1,5-diene,2-methanidyl-2-methylpropane

C13H23ClPd (320.0523)


   

2-(CHLOROMETHYL)-3-(4-CHLOROPHENYL)-2-METHYL-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE

2-(CHLOROMETHYL)-3-(4-CHLOROPHENYL)-2-METHYL-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE

C16H14Cl2N2O (320.0483)


   

2-butoxyethyl 2,4-dichlorophenoxyacetate

2-butoxyethyl 2,4-dichlorophenoxyacetate

C14H18Cl2O4 (320.0582)


   

Bis(1-naphthyl)chlorophosphine,

Bis(1-naphthyl)chlorophosphine,

C20H14ClP (320.0522)


   

5-(2-CHLORO-1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHOXY)PHENYL]-1,2,4-OXADIAZOLE

5-(2-CHLORO-1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHOXY)PHENYL]-1,2,4-OXADIAZOLE

C13H12ClF3N2O2 (320.0539)


   

(5s)-2-{[(1s)-1-(2-Fluorophenyl)ethyl]amino}-5-Methyl-5-(Trifluoromethyl)-1,3-Thiazol-4(5h)-One

(5s)-2-{[(1s)-1-(2-Fluorophenyl)ethyl]amino}-5-Methyl-5-(Trifluoromethyl)-1,3-Thiazol-4(5h)-One

C13H12F4N2OS (320.0606)


   

3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-4-one

3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-4-one

C15H12O8 (320.0532)


   

2-[(6-chloro-1-benzotriazolyl)oxy]-N-(4-fluorophenyl)acetamide

2-[(6-chloro-1-benzotriazolyl)oxy]-N-(4-fluorophenyl)acetamide

C14H10ClFN4O2 (320.0476)


   

2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-2,3-dihydrochromen-4-one

2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-2,3-dihydrochromen-4-one

C15H12O8 (320.0532)


   

7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-1H,10H-pyrano[4,3-b]chromene-9-carboxylic acid

7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-1H,10H-pyrano[4,3-b]chromene-9-carboxylic acid

C15H12O8 (320.0532)


An organic heterotricyclic compound that is 1H,10H-pyrano[4,3-b]chromene substituted by hydroxy groups at positions 7 and 8, a methoxy group at position 1, a methyl group at position 3 and an oxo group at position 10. Isolated from Chaetomium funicola, it exhibits inhibitory activity against metallo-beta-lactamases.

   

THYMIDINE 5-MONOPHOSPHATE

THYMIDINE 5-MONOPHOSPHATE

C10H13N2O8P-2 (320.041)


   

thymidine 3-monophosphate

thymidine 3-monophosphate

C10H13N2O8P-2 (320.041)


   

Octulose 8-phosphate

Octulose 8-phosphate

C8H17O11P (320.0508)


A ketooctose derivative that is D-glycero-D-altro-octulose carrying a single phosphate substituent at position 8.

   

[(2R,3R,4S,5S)-3,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl] dihydrogen phosphate

[(2R,3R,4S,5S)-3,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl] dihydrogen phosphate

C8H17O11P (320.0508)


   

[(2R,3R,4R,5R,6S,7R)-2,3,4,5,6,7-hexahydroxy-8-oxooctyl] dihydrogen phosphate

[(2R,3R,4R,5R,6S,7R)-2,3,4,5,6,7-hexahydroxy-8-oxooctyl] dihydrogen phosphate

C8H17O11P (320.0508)


   

[(2R,3R)-2,3-dihydroxy-3-[(3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]propyl] dihydrogen phosphate

[(2R,3R)-2,3-dihydroxy-3-[(3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]propyl] dihydrogen phosphate

C8H17O11P (320.0508)


   

(-)-Dihydromyricetin

(-)-Dihydromyricetin

C15H12O8 (320.0532)


The (2S,3S)-stereoisomer of dihydromyricetin.

   

5-Nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester

5-Nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester

C14H12N2O5S (320.0467)


   

1-[(2,4-dichlorophenyl)methyl]-3-[(E)-2-phenylethenyl]urea

1-[(2,4-dichlorophenyl)methyl]-3-[(E)-2-phenylethenyl]urea

C16H14Cl2N2O (320.0483)


   

3-(3,4-Dihydroxyphenyl)-1-(2,3,4,5,6-pentahydroxyphenyl)prop-2-en-1-one

3-(3,4-Dihydroxyphenyl)-1-(2,3,4,5,6-pentahydroxyphenyl)prop-2-en-1-one

C15H12O8 (320.0532)


   

[(3S,4R,5R,6R,7R)-3,4,5,6,7,8-hexahydroxy-2-oxooctyl] dihydrogen phosphate

[(3S,4R,5R,6R,7R)-3,4,5,6,7,8-hexahydroxy-2-oxooctyl] dihydrogen phosphate

C8H17O11P (320.0508)


   

Ampelopsin

4H-1-Benzopyran-4-one, 2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, (2R-trans)-

C15H12O8 (320.0532)


(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as a metabolite, an antioxidant and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin. Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus). Dihydromyricetin is a naturally occurring flavonoid found in the many plant species and is thought to be the active ingredient of several traditional Japanese, Chinese, and Korean medicines that are used to treat fever, parasite infections, liver diseases, and hangovers. Dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice. Dihydromyricetin is a natural product found in Vitis rotundifolia, Catha edulis, and other organisms with data available. An optically active form of dihydromyricetin having (2R,3R)-configuration. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.

   

dTMP(2-)

dTMP(2-)

C10H13N2O8P (320.041)


A 2-deoxyribonucleoside 5-monophosphate(2-) obtained by deprotonation of the phosphate OH groups of dTMP; major species at pH 7.3.

   

(2E,4E)-2,4-Dihydroxy-4-[6-(4-hydroxyphenyl)-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene]but-2-enoate

(2E,4E)-2,4-Dihydroxy-4-[6-(4-hydroxyphenyl)-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene]but-2-enoate

C15H12O8 (320.0532)


   

2-chloro-7-hydroxy-3,9-dimethoxy-1-methylbenzo[c]chromen-6-one

2-chloro-7-hydroxy-3,9-dimethoxy-1-methylbenzo[c]chromen-6-one

C16H13ClO5 (320.0451)


   

4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid

4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid

C15H12O8 (320.0532)


   

(3s)-4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione

(3s)-4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione

C15H12O8 (320.0532)


   

4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione

4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione

C15H12O8 (320.0532)


   

1,4-dihydroxy-6-methoxy-5,8-dioxo-3-(2-oxopropyl)naphthalene-2-carboxylic acid

1,4-dihydroxy-6-methoxy-5,8-dioxo-3-(2-oxopropyl)naphthalene-2-carboxylic acid

C15H12O8 (320.0532)


   

2-o-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-phenylaceticacid

NA

C15H12O8 (320.0532)


{"Ingredient_id": "HBIN006164","Ingredient_name": "2-o-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-phenylaceticacid","Alias": "NA","Ingredient_formula": "C15H12O8","Ingredient_Smile": "C1=CC(=C(C=C1C(=O)OC2=CC(=CC(=C2CC(=O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5767","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3,5,7,2',6'-pentahydroxy flavonol

NA

C15H12O8 (320.0532)


{"Ingredient_id": "HBIN007566","Ingredient_name": "3,5,7,2',6'-pentahydroxy flavonol","Alias": "NA","Ingredient_formula": "C15H12O8","Ingredient_Smile": "C1=CC(=C(C(=C1)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)(O)O)O","Ingredient_weight": "320.25 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT19413","TCMID_id": "31765","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129892149","DrugBank_id": "NA"}

   

5-(2-carboxy-3-hydroxy-5-methoxyphenyl)-4-methyl-6-oxopyran-2-carboxylic acid

5-(2-carboxy-3-hydroxy-5-methoxyphenyl)-4-methyl-6-oxopyran-2-carboxylic acid

C15H12O8 (320.0532)


   

ethyl (1r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate

ethyl (1r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate

C15H12O8 (320.0532)


   

4-chloro-1,3,10-trihydroxy-8-methoxy-6-methyl-10h-anthracen-9-one

4-chloro-1,3,10-trihydroxy-8-methoxy-6-methyl-10h-anthracen-9-one

C16H13ClO5 (320.0451)


   

4-(2-carboxy-3-hydroxy-5-methoxyphenyl)-3-methyl-6-oxopyran-2-carboxylic acid

4-(2-carboxy-3-hydroxy-5-methoxyphenyl)-3-methyl-6-oxopyran-2-carboxylic acid

C15H12O8 (320.0532)


   

1,3,6,8-tetrahydroxy-2,5-dimethoxyxanthen-9-one

1,3,6,8-tetrahydroxy-2,5-dimethoxyxanthen-9-one

C15H12O8 (320.0532)


   

(2z,4s)-4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid

(2z,4s)-4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid

C15H12O8 (320.0532)


   

(1s)-1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-1h-cyclohexa[g]isochromene-6,9-dione

(1s)-1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-1h-cyclohexa[g]isochromene-6,9-dione

C15H12O8 (320.0532)


   

(2r,3s)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

(2r,3s)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

C15H12O8 (320.0532)


   

ethyl (2r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-2-carboxylate

ethyl (2r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-2-carboxylate

C15H12O8 (320.0532)


   

1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-1h-cyclohexa[g]isochromene-6,9-dione

1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-1h-cyclohexa[g]isochromene-6,9-dione

C15H12O8 (320.0532)


   

(2s)-2,4,6-trihydroxy-2-[(3,4,5-trihydroxyphenyl)methyl]-1-benzofuran-3-one

(2s)-2,4,6-trihydroxy-2-[(3,4,5-trihydroxyphenyl)methyl]-1-benzofuran-3-one

C15H12O8 (320.0532)


   

1,3,6,8-tetrahydroxy-2,7-dimethoxyxanthen-9-one

1,3,6,8-tetrahydroxy-2,7-dimethoxyxanthen-9-one

C15H12O8 (320.0532)


   

(2z)-4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid

(2z)-4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid

C15H12O8 (320.0532)


   

(2r,3s)-2,6,8-trihydroxy-3-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

(2r,3s)-2,6,8-trihydroxy-3-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

C15H12O8 (320.0532)


   

2,6,8-trihydroxy-3-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

2,6,8-trihydroxy-3-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one

C15H12O8 (320.0532)


   

(2r,3r,5r)-5-[(1r)-1-bromopropyl]-3-chloro-2-[(2z,5e)-hepta-2,5-dien-1-yl]oxolane

(2r,3r,5r)-5-[(1r)-1-bromopropyl]-3-chloro-2-[(2z,5e)-hepta-2,5-dien-1-yl]oxolane

C14H22BrClO (320.0542)


   

(10r)-4-chloro-1,3,10-trihydroxy-8-methoxy-6-methyl-10h-anthracen-9-one

(10r)-4-chloro-1,3,10-trihydroxy-8-methoxy-6-methyl-10h-anthracen-9-one

C16H13ClO5 (320.0451)


   

ethyl 7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-2-carboxylate

ethyl 7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-2-carboxylate

C15H12O8 (320.0532)


   

(2r,11e,15e)-16-bromohexadeca-11,15-dien-3,5,13-triyne-1,2-diol

(2r,11e,15e)-16-bromohexadeca-11,15-dien-3,5,13-triyne-1,2-diol

C16H17BrO2 (320.0412)


   

5,8-dihydroxy-6-methoxy-1,4-dioxo-3-(2-oxopropyl)naphthalene-2-carboxylic acid

5,8-dihydroxy-6-methoxy-1,4-dioxo-3-(2-oxopropyl)naphthalene-2-carboxylic acid

C15H12O8 (320.0532)